FDA Grants Approval to Medtronic’s Artificial Pancreas
The FDA has approved the first artificial pancreas, which automatically monitors glucose and provides the appropriate insulin dose.
Medtronic’s MiniMed 670G hybrid closed-loop system is indicated for patients with type 1 diabetes who are 14 years of age and older.
The device has a sensor that attaches to the body under the skin and an insulin pump that is strapped to the body. An infusion patch connects to the pump to deliver the basal insulin. — Tamra Sami